CAS Medical Systems Inc (CASM)

Sector:
HEALTH CARE
Industry:
HEALTH CARE SUPPLIES
SIC:
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
CEO:
Thomas M. Patton
Employees:
73
44 EAST INDUSTRIAL ROAD, BRANFORD, CT 06405
2034886056

*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

CAS Medical Systems, Inc. develops, manufactures, and markets non-invasive patient monitoring products that are vital to patient care. Its products include the FORE-SIGHT Absolute Tissue Oximeter and sensors, and its traditional monitoring products which include MAXNIBP blood pressure measurement technology. These products are designed to provide accurate, non-invasive, biologic measurements that guide clinicians to provide better patient care. The company was founded in 1984 and is headquartered in Branford, CT.

Data derived from most recent annual or quarterly report
Market Cap 71.885 Million Shares Outstanding29.341 Million Avg 30-day Volume 79.75 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-0.28
Price to Revenue2.1417 Debt to Equity-4.3211 EBITDA-2.932 Million
Price to Book Value0.0 Operating Margin-20.4894 Enterprise Value67.391 Million
Current Ratio2.328 EPS Growth-1 Quick Ratio1.858
1 Yr BETA 0.9341 52-week High/Low 0.0 / Profit Margin-27.1951
Operating Cash Flow Growth-494.8079 Free Cash Flow to Firm (FCFF) TTM -2.41 Million Free Cash Flow to Equity (FCFE) TTM-1.675 Million
Altman Z-Score-3.0603
View SEC Filings from CASM instead.

View recent insider trading info

Funds Holding CASM (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding CASM

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Events (8k)

  • 8-K: filed on 2019-04-09:
    Item 8.01: Other Events
  • 8-K: filed on 2019-02-12:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2019-01-03:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2018-10-31:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2018-05-10:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2018-05-08:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 1.02: Termination of a Material Definitive Agreement
    Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
    Item 3.02: Unregistered Sales of Equity Securities
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2018-03-14:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2018-01-29:
    Item 8.01: Other Events
  • 8-K: filed on 2018-01-04:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2017-11-09:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • Proposed Sales (Form 144)

    Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    EDWARDS LIFESCIENCES HOLDING, INC.

    EDWARDS LIFESCIENCES CORP

    • 10% Owner
    40,049,789 2019-04-18 0

    THOMAS JAMES E

    • Director
    • 10% Owner
    No longer subject to file 2019-04-18 0

    MILINAZZO ALAN

    • Director
    No longer subject to file 2019-04-18 0

    WEISSHAAR KENNETH R

    • Director
    No longer subject to file 2019-04-18 0

    BAIRD JEFFERY A CHIEF FINANCIAL OFFICER

    • Officer
    No longer subject to file 2019-04-18 0

    PATTON THOMAS M PRESIDENT AND CEO

    • Officer
    • Director
    No longer subject to file 2019-04-18 0

    THOMAS, MCNERNEY & PARTNERS II L.P.

    THOMAS, MCNERNEY & PARTNERS II, LLC

    TMP ASSOCIATES II LP

    TMP NOMINEE II, LLC

    • 10% Owner
    No longer subject to file 2019-04-18 0

    RAINEY GREGORY P

    • Director
    No longer subject to file 2019-04-18 0

    TUNE KATHLEEN A

    • Director
    No longer subject to file 2019-04-18 0

    GAMELIN JOHN VICE PRESIDENT, R&D

    • Officer
    No longer subject to file 2019-04-18 0

    BENNI PAUL CHIEF SCIENTIFIC OFFICER

    • Officer
    No longer subject to file 2019-04-18 0

    MOLLOY PAUL A

    • Director
    No longer subject to file 2019-04-18 0

    ACUTA CAPITAL FUND, LP

    • 10% Owner
    3,483,146 2018-01-04 0

    FLYNN JAMES E

    DEERFIELD MGMT L.P.

    DEERFIELD MANAGEMENT CO

    DEERFIELD SPECIAL SITUATIONS FUND, L.P.

    • 10% Owner
    • POSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUP
    No longer subject to file 2017-01-24 0

    WAGNER BRIAN J CHIEF COMMERCIAL OFFICER

    • Officer
    5,400 2015-05-28 0

    FLYNN JAMES E

    DEERFIELD MGMT L.P.

    DEERFIELD MANAGEMENT CO

    DEERFIELD SPECIAL SITUATIONS FUND, L.P.

    DEERFIELD SPECIAL SITUATIONS INTERNATIONAL MASTER FUND, L.P.

    • 10% Owner
    • POSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUP
    3,200,000 2015-01-01 0

    BURSTEIN LAWRENCE

    • Director
    124,060 2014-06-25 0

    JONES EVAN/ FA

    • Director
    378,101 2013-06-24 0

    HERWIG MATTHEW J VP OF SALES AND MARKETING

    • Officer
    0 2012-12-17 0

    SCHEPS LOUIS P

    • Director
    141,656 2010-12-07 0

    BARON JEROME

    • Director
    125,431 2010-06-09 0

    KERSEY ANDREW E PRESIDENT AND CEO

    • Officer
    • Director
    40,658 2008-11-20 0

    HARRIS NATHAN VP SALES AND MARKETING

    • Officer
    0 2008-09-15 0

    MILLES SAUL S

    • Director
    3,000 2007-07-16 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed
    Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
    No current insider transactions

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    WhaleWisdom Logo

    Elevate your investments